UBS O'Connor’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,740	Closed	-$1.12M	–	360
2024 Q4	$1.12M	Buy	20,740 +4,740	+30%	+$257K	0.03%	212
2024 Q3	$807K	Buy	+16,000	New	+$807K	0.02%	295